Category: Wall Street BeatSyndicate content

Philips sells stake in lighting biz for $3B

March 31, 2015 by MassDevice

Royal Philips deals an 80% stake in its lighting components business to Go Scale Capital for $nearly $3 billion.

Philips sells stake in lighting biz for $3B

Olympus to pay $92m to settle accounting fraud case

March 27, 2015 by MassDevice

Olympus says it agreed to pay $92 million to settle a pair of civil lawsuits brought over the 2001 accounting scandal that nearly brought the company down.

Olympus to pay $92m to settle accounting fraud case

Johnson & Johnson taps Google for robot-assisted surgery program

March 27, 2015 by Brad Perriello

Johnson & Johnson inks a deal with Google to develop a robot-assisted surgery device.

Johnson & Johnson taps Google for robot-assisted surgery program

ReWalk Robotics plans Q2 launch in India

March 27, 2015 by MassDevice

ReWalk Robotics plans to launch its wearable robotic exoskeleton device in India by the 2nd quarter.

ReWalk Robotics plans Q2 launch in India

(Reuters) — ReWalk Robotics (NSDQ:RWLK) plans to launch its wearable robotic exoskeleton in India by the 2nd quarter, CEO Larry Jasinski said.

CRM: BSX's gain is STJ's loss | Medtech Wall Street news for the week of March 23, 2015

March 26, 2015 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Boston Scientific's gain is St. Jude Medical's loss; Abiomed soars to new all-time high on FDA nod; Philips mulls 2016 IPO for lighting biz as bidding war heats up; SteadyMed prices $40m IPO well under range; Becton Dickinson to shed assets after CareFusion buy

CRM: Boston Scientific's gain is St. Jude Medical's loss

March 20, 2015 by Brad Perriello

Diabetes: Valeritas delays $75m IPO

March 26, 2015 by Brad Perriello

Valeritas delays an initial public offering that would have brought in $75 million at the midpoint.

Diabetes: Valeritas delays $75m IPO

Valeritas today postponed its planned initial public offering, which at the midpoint was slated to fetch $75 million for its V-Go basal insulin delivery system for Type II diabetes, Renaissance Capital reported.

Earlier this month Valeritas said it planned to put up 5 million shares at $14 to $16 each.

Report: Becton Dickinson to shed assets after CareFusion buy

March 25, 2015 by Brad Perriello

Becton Dickinson is reportedly planning to shed its respiratory devices business now that it's closed its $12.4 billion acquisition of CareFusion.

Report: Becton Dickinson to shed assets after CareFusion buy

Get the complete picture with a MassDevice Plus membership. Registered users can login here.